Michael Hedenus

2.2k total citations
42 papers, 1.6k citations indexed

About

Michael Hedenus is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Michael Hedenus has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 17 papers in Genetics and 11 papers in Oncology. Recurrent topics in Michael Hedenus's work include Erythropoietin and Anemia Treatment (27 papers), Iron Metabolism and Disorders (16 papers) and Hemoglobinopathies and Related Disorders (14 papers). Michael Hedenus is often cited by papers focused on Erythropoietin and Anemia Treatment (27 papers), Iron Metabolism and Disorders (16 papers) and Hemoglobinopathies and Related Disorders (14 papers). Michael Hedenus collaborates with scholars based in Sweden, United States and Austria. Michael Hedenus's co-authors include Anders Österborg, Yvonne Brandberg, Steven Fishbane, Stefanie Howaldt, János Szebeni, S Patni, David S. Rampton, Francesco Locatelli, Diethelm Messinger and Genadi Iosava and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Michael Hedenus

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hedenus Sweden 18 1.3k 532 359 273 180 42 1.6k
David H. Regan United States 7 774 0.6× 263 0.5× 252 0.7× 196 0.7× 97 0.5× 9 991
Brenda Sarokhan United States 10 953 0.8× 254 0.5× 286 0.8× 214 0.8× 165 0.9× 11 1.2k
Tim Littlewood United Kingdom 23 1.3k 1.0× 582 1.1× 345 1.0× 94 0.3× 75 0.4× 62 1.8k
Stanley E. Gräber United States 18 1.1k 0.9× 364 0.7× 151 0.4× 164 0.6× 138 0.8× 42 1.7k
Timothy J. Littlewood United Kingdom 29 2.4k 1.9× 884 1.7× 802 2.2× 389 1.4× 425 2.4× 61 3.2k
Jan Hastka Germany 15 584 0.5× 373 0.7× 100 0.3× 88 0.3× 78 0.4× 42 1.0k
Y Beguin Belgium 19 698 0.6× 459 0.9× 111 0.3× 30 0.1× 74 0.4× 39 1.1k
Jeffrey A. Gilreath United States 12 378 0.3× 173 0.3× 192 0.5× 78 0.3× 52 0.3× 34 725
Roberto Castelli Italy 21 553 0.4× 670 1.3× 230 0.6× 34 0.1× 37 0.2× 86 1.6k
Leo J. McCarthy United States 16 501 0.4× 222 0.4× 99 0.3× 54 0.2× 47 0.3× 46 1.3k

Countries citing papers authored by Michael Hedenus

Since Specialization
Citations

This map shows the geographic impact of Michael Hedenus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hedenus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hedenus more than expected).

Fields of papers citing papers by Michael Hedenus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hedenus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hedenus. The network helps show where Michael Hedenus may publish in the future.

Co-authorship network of co-authors of Michael Hedenus

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hedenus. A scholar is included among the top collaborators of Michael Hedenus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hedenus. Michael Hedenus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirker, Robert, et al.. (2015). Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL. Clinical Therapeutics. 38(1). 122–135.e6. 5 indexed citations
2.
Rampton, David S., Steven Fishbane, Michael Hedenus, et al.. (2014). Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica. 99(11). 1671–1676. 220 indexed citations
3.
Hedenus, Michael, et al.. (2014). Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Medical Oncology. 31(12). 302–302. 31 indexed citations
4.
Favrat, Bernard, Christian Breymann, Michael Hedenus, et al.. (2014). Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women – PREFER a Randomized, Placebo-Controlled Study. PLoS ONE. 9(4). e94217–e94217. 99 indexed citations
5.
Vansteenkiste, Johan, et al.. (2013). Chemotherapy-induced anemia: the story of darbepoetin alfa. Current Medical Research and Opinion. 29(4). 325–337. 7 indexed citations
6.
7.
Boer, Richard de, Michael Clemens, Dusan Kotasek, et al.. (2010). Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies. Medical Oncology. 28(4). 1210–1217. 2 indexed citations
8.
9.
Wåhlin, Anders, Rolf Billström, Ove Björ, et al.. (2009). Results of risk‐adapted therapy in acute myeloid leukaemia. A long‐term population‐based follow‐up study. European Journal Of Haematology. 83(2). 99–107. 34 indexed citations
10.
Hedenus, Michael & Gunnar Birgegård. (2008). The role of iron supplementation during epoietin treatment for cancer-related anemia. Medical Oncology. 26(1). 105–115. 18 indexed citations
11.
Hedenus, Michael, et al.. (2008). Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy. Journal of Clinical Pharmacy and Therapeutics. 33(4). 365–374. 12 indexed citations
12.
Littlewood, Timothy J., Joel Kallich, Jesús F. San Miguel, Lisa Hendricks, & Michael Hedenus. (2006). Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative Malignancies. Journal of Pain and Symptom Management. 31(4). 317–325. 33 indexed citations
13.
Österborg, Anders, Yvonne Brandberg, & Michael Hedenus. (2005). Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study*. British Journal of Haematology. 129(2). 206–209. 46 indexed citations
14.
Hedenus, Michael, Magnus Adriansson, Jesús F. San Miguel, et al.. (2003). Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study. British Journal of Haematology. 122(3). 394–403. 267 indexed citations
15.
Höglund, Martin, Mats Brune, Bengt Sallerfors, et al.. (2003). More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML. Bone Marrow Transplantation. 32(12). 1119–1124. 2 indexed citations
16.
Österborg, Anders, Yvonne Brandberg, Genadi Iosava, et al.. (2002). Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies. Journal of Clinical Oncology. 20(10). 2486–2494. 236 indexed citations
17.
Hedenus, Michael, et al.. (2000). A randomized, blinded, placebo-controlled, phase II, dose-finding study of ARANESP (TM) in patients with lymphoproliferative malignancies.. Blood. 96(11). 15516. 4 indexed citations
18.
Brincker, H, Niels Abildgaard, Peter Gimsing, et al.. (1998). Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial. British Journal of Haematology. 101(2). 280–286. 83 indexed citations
19.
Wåhlin, Anders, Lorentz Brinch, Stein A. Evensen, et al.. (1997). Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia. European Journal Of Haematology. 58(4). 233–240. 7 indexed citations
20.
Juliusson, Gunnar, Dag Heldal, Erik Hippe, et al.. (1995). Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.. Journal of Clinical Oncology. 13(4). 989–995. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David H. Regan Breakdown of academic impact, for papers by Brenda Sarokhan Breakdown of academic impact, for papers by Tim Littlewood Breakdown of academic impact, for papers by Stanley E. Gräber Breakdown of academic impact, for papers by Timothy J. Littlewood Breakdown of academic impact, for papers by Jan Hastka Breakdown of academic impact, for papers by Y Beguin Breakdown of academic impact, for papers by Jeffrey A. Gilreath Breakdown of academic impact, for papers by Roberto Castelli Breakdown of academic impact, for papers by Leo J. McCarthy
Rankless by CCL
2026